<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE resolution PUBLIC "-//US Congress//DTDs/res.dtd//EN" "res.dtd">
<resolution resolution-stage="Introduced-in-House" dms-id="H7F30C7BDC4264FB2BA3C90454CCD2F8D" public-private="public" resolution-type="house-resolution" star-print="no-star-print" key="H"><metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>116 HRES 860 IH: Recognizing the rise of cardiovascular disease as the world’s leading cause of preventable death and disability and as a global public health crisis and supporting the recognition of February 2020 as “American Heart Month”.</dc:title>
<dc:publisher>U.S. House of Representatives</dc:publisher>
<dc:date>2020-02-14</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
<distribution-code display="yes">IV</distribution-code><congress display="yes">116th CONGRESS</congress><session display="yes">2d Session</session><legis-num display="yes">H. RES. 860</legis-num><current-chamber>IN THE HOUSE OF REPRESENTATIVES</current-chamber><action display="yes"><action-date date="20200214">February 14, 2020</action-date><action-desc><sponsor name-id="S000522">Mr. Smith of New Jersey</sponsor> (for himself and <cosponsor name-id="B001281">Mrs. Beatty</cosponsor>) submitted the following resolution; which was referred to the <committee-name committee-id="HFA00">Committee on Foreign Affairs</committee-name>, and in addition to the Committee on <committee-name committee-id="HIF00">Energy and Commerce</committee-name>, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned</action-desc></action><legis-type>RESOLUTION</legis-type><official-title display="yes">Recognizing the rise of cardiovascular disease as the world’s leading cause of preventable death and disability and as a global public health crisis and supporting the recognition of February 2020 as <quote>American Heart Month</quote>.</official-title></form><preamble><whereas><text>Whereas the World Health Organization estimates that in 2017, 17.8 million people died from cardiovascular diseases (referred to in this resolution as <quote>CVDs</quote>) globally;</text></whereas><whereas><text>Whereas of these deaths, 85 percent were due to heart attacks and strokes, and over three-quarters of CVD deaths occur in low- and middle-income countries;</text></whereas><whereas><text>Whereas CVDs result in tremendous health care costs and lost productivity and, if not addressed, the United States alone will spend over $1,000,000,000 by 2035 on costs relating to CVD;</text></whereas><whereas><text>Whereas the heavy burden of death and disability from CVDs can be decreased through changes in behavior linked to major risk factors, including reduced tobacco use and salt consumption and improvements in access to medical treatment and services;</text></whereas><whereas><text>Whereas essential quality-assured medicines and technologies are critical components to address the global burden of CVDs; and</text></whereas><whereas><text>Whereas United States leadership and support has strengthened surveillance, enhanced workforce capacity, and provided valuable technical exchanges with respect to the prevention, diagnosis, and treatment of CVD: Now, therefore, be it</text></whereas></preamble><resolution-body style="traditional" id="H0687C06F158641B791A34D06C624FD80"><section id="HEA9CD7F18D084CE0B0C6A9702D95CE4F" section-type="undesignated-section" display-inline="yes-display-inline"><enum/><text display-inline="yes-display-inline">That the House of Representatives—</text><paragraph id="HCCE0D0846D4C44A0A368A9EC231D0EA7"><enum>(1)</enum><text display-inline="yes-display-inline">supports the recognition of American Heart Month to bring awareness to the cardiovascular disease (hereinafter referred to as <quote>CVD</quote>) public health crisis in the United States and abroad;</text></paragraph><paragraph id="H6FB63BEF850E4D2C95D3AC33C475CD17"><enum>(2)</enum><text>affirms that the key to overcoming CVD is prevention and early detection and treatment to reduce long-term disability and mortality;</text></paragraph><paragraph id="HC9489E35A77E455CB3B2883E7A761339"><enum>(3)</enum><text>urges the deployment of United States technical expertise on CVDs in support of developing capacities and strengthening of the health care systems of other countries;</text></paragraph><paragraph id="HE64AA1D9B3C94F42AEA598D2F9CD0824"><enum>(4)</enum><text>values the quality of life for CVD patients around the world and their reintegration to society; and</text></paragraph><paragraph id="HB6EE994689DF4E3AA6614E98D68B8F44"><enum>(5)</enum><text>calls on the Department of State, the United States Agency for International Development, and the Centers for Disease Control and Prevention, to—</text><subparagraph id="HAE603DE29CEC424ABE3C4AE470A76F3D"><enum>(A)</enum><text>comprehensively examine the impact of CVDs on health and development in United States priority assistance countries; and</text></subparagraph><subparagraph id="H601676CA0E4C4FC2A873061B480000F4"><enum>(B)</enum><text>develop a coordinated strategy that improves the effectiveness and impact of United States-financed global health programming by integrating CVD into existing programs.</text></subparagraph></paragraph></section></resolution-body></resolution> 

